mRNA vs Immunity: Dr. Astrid Lefringhausen on Risk Benefit Ratio of COVID Vaccines – Ask Dr. Drew
“It is truly disturbing that treatments recommended by doctors in America, some of them having successfully treated COVID-19 patients, including very sick patients, have not been investigated in Australia,” says a paper co-authored by Dr. Astrid Lefringhausen. “Yet here in Australia the recommendation is to isolate and monitor yourself.”
Dr. Astrid Lefringhausen is an Australian doctor with a PhD in Microbiology and Biochemistry and a Doctorate in Molecular Biology / Virology. She has decades of international industry experience in molecular biology, stem cell therapy, and immunology.
(Dr. Lefringhausen is not currently active on social media)